Acrivon Therapeutics, Inc. Common Stock

NASDAQ:ACRV

Biotechnology

Healthcare
$1.40 +3.16%

+$0.05 today

Market cap
$60.08M
Beta
1.91
P/E (TTM)
-0.8
EPS (TTM)
-$2.00
52W Low $1.15High $3.56

Volume 0.37M

Average 0.60M

Balance Sheet

Inspect the capital base behind the business.

Assets

$129.72M

FY 2025 · Annual

-34.0% YoY

Liabilities

$17.20M

FY 2025 · Annual

-13.1% YoY

Equity

$112.52M

FY 2025 · Annual

-36.4% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents99.6M29.52M36.02M39.82M41.5M
Short-term Investments098.23M91.44M139.66M77.08M
Net Receivables00000
Inventory00000
Other Current Assets04.34M2.23M2.15M1.86M
Total Current Assets100.41M132.1M129.69M181.63M120.45M
Property, Plant & Equipment (Net)5.79M6.86M7.91M8.03M7.42M
Goodwill00000
Intangible Assets00000
Long-term Investments041.88M05.09M0
Tax Assets00000
Other Non-current Assets388K388K665K1.85M1.86M
Total Non-current Assets6.18M49.13M8.57M14.96M9.27M
Total Assets106.59M181.23M138.27M196.59M129.72M
Account Payables964K904K5.05M758K2.28M
Short-term Debt0001.06M0
Tax Payables00000
Deferred Revenue66K69K000
Other Current Liabilities667K2.66M3.86M5.46M5.56M
Total Current Liabilities2.91M6.52M13.3M17.21M15.66M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities122.52M0000
Total Non-current Liabilities127.48M4.24M3.77M2.59M1.54M
Total Liabilities130.4M10.75M17.07M19.8M17.2M
Common Stock2K22K23K31K31K
Retained Earnings(24.87M)(56.03M)(116.42M)(196.98M)(274.88M)
Accumulated OCI0(95K)(83K)447K111K
Other Stockholders Equity00000
Minority Interest00000
Total Equity(23.81M)170.48M121.2M176.79M112.52M
Total Debt5.63M4.96M4.64M3.65M2.71M
Net Debt(93.98M)(24.56M)(31.37M)(36.17M)(38.79M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$34.1M
Short-term Investments$63.7M
Other Current$1.5M
Total Current Assets$99.2M
PP&E (Net)$6.9M
Other Non-current$1.7M
Total Non-current Assets$8.6M
Total Assets$107.8M

Analysis

Selected assets total $107.8M for Latest. The largest visible component is Short-term Investments at $63.7M, about 59.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
8-KCurrent reportNov 6, 2026
4Statement of changes in beneficial ownershipOct 26, 2026
4Statement of changes in beneficial ownershipOct 7, 2026
4Statement of changes in beneficial ownershipSep 2, 2026

How much cash does ACRV have?

Acrivon Therapeutics, Inc. Common Stock (ACRV) reported $41.50M in cash and equivalents in fiscal 2025.

How much debt does ACRV carry?

Acrivon Therapeutics, Inc. Common Stock (ACRV) reported $2.71M of total debt, with net debt of -$38.79M.